• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆管癌的流行病学与危险因素

Epidemiology and Risk Factors of Cholangiocarcinoma.

作者信息

Kirstein Martha M, Vogel Arndt

机构信息

Department of Gastroenterology, Hepatology und Endocrinology, Hanover Medical School, Hanover, Germany.

出版信息

Visc Med. 2016 Dec;32(6):395-400. doi: 10.1159/000453013. Epub 2016 Dec 1.

DOI:10.1159/000453013
PMID:28229073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5290446/
Abstract

BACKGROUND

Cholangiocarcinoma (CCA) is the second most common primary liver cancer, being characterized by its late diagnosis and fatal outcome. Recent epidemiological reports indicate an increasing worldwide incidence of intrahepatic CCA but a decreasing incidence of extrahepatic CCA.

METHODS

In this review, we present an overview of the incidence and epidemiology of CCA and possible strategies for screening and surveillance.

RESULTS

Efficient strategies for the screening and surveillance of CCA have not been established so far. The vast majority of CCA occur sporadically without any apparent cause; however, several risk factors such as liver flukes, chronic biliary and liver diseases, and lifestyle-related aspects causing chronic inflammation and cholestasis in the liver have been linked to the development of CCA. These risk factors likely contribute to the increased incidence observed in some countries and also explain the wide geographical differences in the incidence of CCA.

CONCLUSION

Several risk factors for CCA have been identified. Given the dismal prognosis of advanced CCA, regular surveillance examinations with a combination of ultrasonography and laboratory tests appear to be useful in patients at risk and need to be explored in prospective trials.

摘要

背景

胆管癌(CCA)是第二常见的原发性肝癌,其特点是诊断较晚且预后不良。近期流行病学报告显示,全球肝内胆管癌发病率呈上升趋势,而肝外胆管癌发病率呈下降趋势。

方法

在本综述中,我们概述了胆管癌的发病率、流行病学以及可能的筛查和监测策略。

结果

目前尚未建立有效的胆管癌筛查和监测策略。绝大多数胆管癌为散发性,无明显病因;然而,一些危险因素,如肝吸虫、慢性胆道和肝脏疾病以及导致肝脏慢性炎症和胆汁淤积的生活方式相关因素,已与胆管癌的发生有关。这些危险因素可能导致一些国家观察到的发病率上升,也解释了胆管癌发病率在地理上的广泛差异。

结论

已确定了胆管癌的几个危险因素。鉴于晚期胆管癌预后不佳,对于高危患者,联合超声检查和实验室检查进行定期监测似乎是有用的,需要在前瞻性试验中进行探索。

相似文献

1
Epidemiology and Risk Factors of Cholangiocarcinoma.胆管癌的流行病学与危险因素
Visc Med. 2016 Dec;32(6):395-400. doi: 10.1159/000453013. Epub 2016 Dec 1.
2
Epidemiology of cholangiocarcinoma.胆管癌的流行病学
Best Pract Res Clin Gastroenterol. 2015 Apr;29(2):221-32. doi: 10.1016/j.bpg.2015.02.003. Epub 2015 Feb 16.
3
Cholangiocarcinoma: Epidemiology and risk factors.胆管癌:流行病学和危险因素。
Liver Int. 2019 May;39 Suppl 1:19-31. doi: 10.1111/liv.14095. Epub 2019 Mar 24.
4
Cancer review: Cholangiocarcinoma.癌症综述:胆管癌。
J Carcinog. 2015 Feb 23;14:1. doi: 10.4103/1477-3163.151940. eCollection 2015.
5
Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma.胆管癌的流行病学、危险因素和发病机制。
HPB (Oxford). 2008;10(2):77-82. doi: 10.1080/13651820801992641.
6
Cholangiocarcinoma Among Children and Adolescents: A Review of the Literature and Surveillance, Epidemiology, and End Results Program Database Analysis.儿童和青少年胆管癌:文献综述及监测、流行病学和最终结果计划数据库分析
J Pediatr Gastroenterol Nutr. 2018 Jan;66(1):e12-e18. doi: 10.1097/MPG.0000000000001749.
7
A review of the clinical diagnosis and therapy of cholangiocarcinoma.胆管癌的临床诊断与治疗综述
J Int Med Res. 2014 Feb;42(1):3-16. doi: 10.1177/0300060513505488. Epub 2013 Dec 23.
8
Surveillance of primary sclerosing cholangitis with ERC and brush cytology: risk factors for cholangiocarcinoma.经内镜逆行胰胆管造影术(ERC)及刷检细胞学检查对原发性硬化性胆管炎的监测:胆管癌的危险因素
Scand J Gastroenterol. 2017 Feb;52(2):242-249. doi: 10.1080/00365521.2016.1250281. Epub 2016 Nov 3.
9
Epidemiology of cholangiocarcinoma.胆管癌的流行病学
Eur J Surg Oncol. 2025 Feb;51(2):107064. doi: 10.1016/j.ejso.2023.107064. Epub 2023 Sep 9.
10
Sex-specific and race/ethnicity-specific disparities in cholangiocarcinoma incidence and prevalence in the USA: An updated analysis of the 2000-2011 Surveillance, Epidemiology and End Results registry.美国胆管癌发病率和患病率的性别及种族/民族差异:对2000 - 2011年监测、流行病学和最终结果登记处数据的更新分析
Hepatol Res. 2016 Jun;46(7):669-77. doi: 10.1111/hepr.12605. Epub 2015 Nov 12.

引用本文的文献

1
Center Experience Is Associated With Improved Survival in Liver Transplantation for Hilar Cholangiocarcinoma: A Retrospective Study.中心经验与肝门部胆管癌肝移植术后生存率提高相关:一项回顾性研究
Transplant Direct. 2025 Jun 27;11(7):e1822. doi: 10.1097/TXD.0000000000001822. eCollection 2025 Jul.
2
Cancer surveillance in biliary atresia patients with native liver survival: Standardizing monitoring and follow-up.对肝生存的胆道闭锁患者进行癌症监测:规范监测与随访。
Pediatr Surg Int. 2025 Jun 12;41(1):165. doi: 10.1007/s00383-025-06066-y.
3
Quantitative MRCP metrics as imaging biomarkers to differentiate benign from malignant bile duct obstructions.作为成像生物标志物的定量磁共振胰胆管造影(MRCP)指标用于鉴别良性与恶性胆管梗阻。
Front Oncol. 2025 May 6;15:1576163. doi: 10.3389/fonc.2025.1576163. eCollection 2025.
4
Factors Contributing to the High Malignancy Level of Cholangiocarcinoma and Its Epidemiology: Literature Review and Data.胆管癌高恶性程度的相关因素及其流行病学:文献综述与数据
Biology (Basel). 2025 Mar 28;14(4):351. doi: 10.3390/biology14040351.
5
Venous thromboembolic complications in patients newly diagnosed with cholangiocarcinoma.新诊断胆管癌患者的静脉血栓栓塞并发症
J Thromb Thrombolysis. 2025 Apr;58(4):566-575. doi: 10.1007/s11239-025-03099-x. Epub 2025 Apr 11.
6
Whole exome sequencing of multi-regions reveals tumor heterogeneity in Opisthorchis viverrini-associated cholangiocarcinoma.多区域全外显子组测序揭示华支睾吸虫相关胆管癌的肿瘤异质性。
Sci Rep. 2025 Mar 29;15(1):10886. doi: 10.1038/s41598-025-95142-3.
7
Establishment and genomic profiling of cholangiocarcinoma cells with functional characterization.具有功能特征的胆管癌细胞的建立与基因组分析
Sci Rep. 2025 Mar 13;15(1):8621. doi: 10.1038/s41598-025-93192-1.
8
Revolutionizing drug delivery: low-intensity pulsed ultrasound (LIPUS)-driven deep penetration into hypoxic tumor microenvironments of cholangiocarcinoma.药物递送的变革:低强度脉冲超声(LIPUS)驱动深入胆管癌缺氧肿瘤微环境。
Theranostics. 2025 Jan 1;15(1):30-51. doi: 10.7150/thno.99981. eCollection 2025.
9
Impact of Clinical Characteristics and Treatment on Cholangiocarcinoma Prognosis in Southern Thailand.泰国南部胆管癌临床特征及治疗对预后的影响
Cancer Med. 2024 Dec;13(24):e70491. doi: 10.1002/cam4.70491.
10
Development of CAR-T Therapies and Personalized Vaccines for the Treatment of Cholangiocarcinoma: Current Progress, Mechanisms of Action, and Challenges.用于治疗胆管癌的嵌合抗原受体T细胞疗法和个性化疫苗的发展:当前进展、作用机制及挑战
Am J Pathol. 2025 Mar;195(3):453-469. doi: 10.1016/j.ajpath.2024.10.021. Epub 2024 Dec 14.

本文引用的文献

1
Potential diagnostic and prognostic biomarkers for cholangiocarcinoma in serum and bile.血清和胆汁中胆管癌潜在的诊断和预后生物标志物。
Biomark Med. 2016 Jun;10(6):613-9. doi: 10.2217/bmm-2015-0062. Epub 2016 May 27.
2
Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published Studies.阿司匹林在癌症治疗中的应用:减少转移扩散和死亡率:已发表研究的系统评价与荟萃分析
PLoS One. 2016 Apr 20;11(4):e0152402. doi: 10.1371/journal.pone.0152402. eCollection 2016.
3
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).专家共识文件:胆管癌:来自欧洲胆管癌研究网络(ENS-CCA)的当前知识和未来展望共识声明。
Nat Rev Gastroenterol Hepatol. 2016 May;13(5):261-80. doi: 10.1038/nrgastro.2016.51. Epub 2016 Apr 20.
4
Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise.美国胆管癌发病率的四十年趋势:肝内疾病呈上升趋势。
Oncologist. 2016 May;21(5):594-9. doi: 10.1634/theoncologist.2015-0446. Epub 2016 Mar 21.
5
Aspirin use and the risk of cholangiocarcinoma.阿司匹林的使用与胆管癌风险
Hepatology. 2016 Sep;64(3):785-96. doi: 10.1002/hep.28529. Epub 2016 Apr 26.
6
Cholelithiasis and the risk of intrahepatic cholangiocarcinoma: a meta-analysis of observational studies.胆结石与肝内胆管癌风险:一项观察性研究的荟萃分析
BMC Cancer. 2015 Nov 2;15:831. doi: 10.1186/s12885-015-1870-0.
7
Sex-specific and race/ethnicity-specific disparities in cholangiocarcinoma incidence and prevalence in the USA: An updated analysis of the 2000-2011 Surveillance, Epidemiology and End Results registry.美国胆管癌发病率和患病率的性别及种族/民族差异:对2000 - 2011年监测、流行病学和最终结果登记处数据的更新分析
Hepatol Res. 2016 Jun;46(7):669-77. doi: 10.1111/hepr.12605. Epub 2015 Nov 12.
8
Screening and surveillance for occupational cholangiocarcinoma in workers exposed to organic solvents.有机溶剂暴露工人职业性胆管癌的筛查与监测。
Surg Today. 2016 Jun;46(6):705-12. doi: 10.1007/s00595-015-1229-9. Epub 2015 Jul 31.
9
Risk factors and correlations of immediate, early delayed, and late delayed bleeding associated with endoscopic resection for gastric neoplasms.胃肿瘤内镜切除术后即刻、早期延迟和晚期延迟出血的危险因素及相关性
Surg Endosc. 2016 Feb;30(2):625-632. doi: 10.1007/s00464-015-4250-6. Epub 2015 Jun 20.
10
Cohort profile: cholangiocarcinoma screening and care program (CASCAP).队列简介:胆管癌筛查与护理项目(CASCAP)
BMC Cancer. 2015 Jun 9;15:459. doi: 10.1186/s12885-015-1475-7.